UK vaccine strategy 'paying off' as latest trials boost stockpiles

Pre-ordering of Janssen and Novavax means Britain has procured 247m successfully trialled jabs

Britain has cemented its status as one of the world’s leading buyers of effective Covid vaccines after two more pharmaceutical companies reported positive trial results – potentially growing the UK stockpile by 90m doses.

The US drugmaker Johnson & Johnson announced on Friday that its vaccine – which requires only one dose – is effective. This followed Thursday’s news that the Novavax vaccine, which will be manufactured in the UK, performed well in phase 3 trials.

Continue reading...

from The Guardian https://ift.tt/3r9pXON

Comments

Popular posts from this blog

‘Help us or LSO fails’: Sir Simon Rattle’s plea over Covid and Brexit

Mark Kermode’s best films of 2019

The Glasgow Effect: examining the city's life expectancy gap – a photo essay